Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could…
Curium and CapVest have announced the recapitalization of Curium via a new Continuation Vehicle The transaction values Curium at circa…
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…
Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility;…
SAN MATEO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel…
KUALA LUMPUR, Malaysia, Nov. 20, 2025 /PRNewswire/ -- At the 2025 Fortune Innovation Forum in Kuala Lumpur, global industry leaders…
MUNICH, Nov. 20, 2025 /PRNewswire/ -- AIRS Medical, known for its award-winning AI-driven MRI solution, SwiftMR™, has rapidly emerged as…
TAMPA, FL / ACCESS Newswire / November 20, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader…
No Reserve | Auction Ends Tonight, Thursday, November 20, 2025 MESA, ARIZONA / ACCESS Newswire / November 20, 2025 /…
VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience…